Full-Service Law Firm solving complex challenges through bold thinking, precise execution, and shared purpose.

Full Service Law Firm | Michael Best & Friedrich LLP

Specializing in the Intersection of Business &amp; Government

Meet our team of trusted advisors, strategic thinkers, and community builders dedicated to client success.

Learn about our full-service legal and business solutions, designed to address complex challenges for leading organizations across industries.

Access thought leadership, news, and resources to stay informed about the latest trends, legal developments, and industry innovations.

Discover how partnership, bold thinking, and precise execution drive results for clients nationwide.

Explore how our national reach and local expertise support clients across the United States and beyond.

Grow at a firm designed to bring out your best.

On May 10, 2023, the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) jointly issued a temporary rule to extend exceptions granted to existing DEA regulations that allow providers to prescribe controlled medications with telemedicine visits even if the provider has not seen the patient in person. This exception began in March 2020 as part of the COVID-19 Public Health Emergency. The extension will apply through November 11, 2023 and provides a grace period for certain telemedicine relationships through November 11, 2024.This is an interim step while the DEA and Health and Human Services (HHS) consider revising proposed rules issued March 1, 2023. Expect to see a final set of one or more rules based on these proposed rules that grant certain telemedicine flexibilities going forward. Interestingly, the extension was limited to six months "in an effort to disincentivize the creation of telemedicine companies that may seek to engage in problematic prescribing practices." The DEA has also indicated they are currently investigating telemedicine companies with troublesome practices leading to overprescribing and potential drug diversion. <input type='hidden' id='passle-remote-hosting-tracking-shortcode' value='102iegz'/><blockquote class="wp-block-quote passle-quote has-cite-link">The Drug Enforcement Administration (DEA) granted temporary exceptions to the Ryan Haight Act and DEA’s implementing regulations thereby allowing the prescribing of controlled medications via telemedicine encounters – even when the prescribing practitioner had not conducted an in-person medical evaluation of the patient.<cite><a href="https://public-inspection.federalregister.gov/2023-09936.pdf" aria-label="public-inspection.federalregister.gov/..." title="https://public-inspection.federalregister.gov/2023-09936.pdf" target="_blank">public-inspection.federalregister.gov/...</a></cite></blockquote>

Telemedicine Flexibilities in Prescribing Extended

Related Capabilities

You may also be interested in these

Why Bylaws Matter More than You Think

Major staffing changes at the US Department of Justice’s Environment and Natural Resources Division

Judges Get New Climate Science Guidance—Here’s Why Industry Is Paying Attention

Related Capabilities

You may also be interested in these

Why Bylaws Matter More than You Think

Major staffing changes at the US Department of Justice’s Environment and Natural Resources Division

Judges Get New Climate Science Guidance—Here’s Why Industry Is Paying Attention

Slide Menu

Slide Search